Published in Clinics (Sao Paulo) on January 01, 2011
Tobacco Smoking and Lung Cancer: Perception-changing facts. Sultan Qaboos Univ Med J (2013) 0.95
Timeliness of Diagnosing Lung Cancer: Number of Procedures and Time Needed to Establish Diagnosis: Being Right the First Time. Medicine (Baltimore) (2015) 0.86
At the crossroads: EGFR and PTHrP signaling in cancer-mediated diseases of bone. Odontology (2012) 0.78
Evaluation of pulmonary nodules in Asian population. J Thorac Dis (2016) 0.75
Smoking and carcinoma of the lung; preliminary report. Br Med J (1950) 55.13
The mortality of doctors in relation to their smoking habits; a preliminary report. Br Med J (1954) 18.11
Erlotinib in lung cancer - molecular and clinical predictors of outcome. N Engl J Med (2005) 13.01
Lung cancer in never smokers--a different disease. Nat Rev Cancer (2007) 6.41
Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon 19 and exon 21 mutations treated with gefitinib or erlotinib. Clin Cancer Res (2006) 5.69
Lung cancer in never smokers: a review. J Clin Oncol (2007) 5.49
Differences in lung cancer risk between men and women: examination of the evidence. J Natl Cancer Inst (1996) 4.91
Lung cancer rates in men and women with comparable histories of smoking. J Natl Cancer Inst (2004) 3.43
Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with different tobacco exposure and clinicopathologic features. Clin Cancer Res (2006) 3.40
Clinicopathologic features of non-small-cell lung cancer with EML4-ALK fusion gene. Ann Surg Oncol (2010) 3.26
Lung cancer incidence in never smokers. J Clin Oncol (2007) 3.20
Lung cancer in 'Never-smokers': a unique entity. Oncology (Williston Park) (2010) 2.95
Never-smokers with lung cancer: epidemiologic evidence of a distinct disease entity. J Clin Oncol (2006) 2.86
Improved survival in never-smokers vs current smokers with primary adenocarcinoma of the lung. Chest (2004) 2.73
Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen. Cancer Res (2002) 2.52
Smoking status as a prognostic factor in patients with stage I pulmonary adenocarcinoma. Ann Thorac Surg (2006) 2.21
Estrogen receptor alpha and beta are prognostic factors in non-small cell lung cancer. Clin Cancer Res (2005) 1.73
Nuclear estrogen receptor beta in lung cancer: expression and survival differences by sex. Clin Cancer Res (2005) 1.59
Presentation and stage-specific outcomes of lifelong never-smokers with non-small cell lung cancer (NSCLC). J Thorac Oncol (2007) 1.55
The significance of estrogen receptor beta in 301 surgically treated non-small cell lung cancers. J Thorac Cardiovasc Surg (2005) 1.55
Lobectomy for treating bronchial carcinoma: analysis of comorbidities and their impact on postoperative morbidity and mortality. J Bras Pneumol (2007) 1.54
Asian ethnicity is a favorable prognostic factor for overall survival in non-small cell lung cancer (NSCLC) and is independent of smoking status. J Thorac Oncol (2009) 1.43
Mutations in the epidermal growth factor receptor gene are linked to smoking-independent, lung adenocarcinoma. Br J Cancer (2005) 1.39
Oestrogen receptor beta over expression in males with non-small cell lung cancer is associated with better survival. Lung Cancer (2007) 1.32
Molecular genetics of lung cancer in people who have never smoked. Lancet Oncol (2008) 1.28
Differences in epidemiology, histology, and survival between cigarette smokers and never-smokers who develop non-small cell lung cancer. Chest (2007) 1.27
Different susceptibility to smoking-induced DNA damage among male and female lung cancer patients. Cancer Res (1994) 1.16
Epidemiology and prevention of lung cancer in nonsmokers. Epidemiol Rev (1998) 1.13
The impact of sex and smoking status on the mutational spectrum of epidermal growth factor receptor gene in non small cell lung cancer. Clin Cancer Res (2007) 1.06
Impact of environmental tobacco smoke on the incidence of mutations in epidermal growth factor receptor gene in never-smoker patients with non-small-cell lung cancer. J Clin Oncol (2009) 1.03
Women and lung cancer: waiting to exhale. Chest (1997) 0.97
Lung cancer: histology, staging, treatment and survival. J Bras Pneumol (2008) 0.82
Characteristics of never smoker lung cancer including environmental and occupational risk factors. Lung Cancer (2009) 0.81
Gender differences in lung cancer: have we really come a long way, baby? J Thorac Cardiovasc Surg (2004) 0.80
On the etiology of lung cancer. J Natl Cancer Inst (1950) 0.78
Lung cancer in 'never-smokers': beyond EGFR mutations and EGFR-TK inhibitors. Oncology (Williston Park) (2010) 0.78
Influence of age on choice of therapy and surgical outcomes in patients with nonsmall cell lung cancer. Am Surg (2009) 0.77
Educational camp for children with asthma. J Bras Pneumol (2008) 1.46
Computed Tomography-Guided Percutaneous Thoracic Duct Sclero-Embolization for Persistent Chylothorax. Innovations (Phila) (2016) 1.16
Reproducibility of the Brazilian Portuguese version of the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire used in conjunction with its lung cancer-specific module. J Bras Pneumol (2010) 0.84
The effects of asthma on dental and facial deformities. J Asthma (2006) 0.83
Anxiety and depression in asthma patients: impact on asthma control. J Bras Pneumol (2011) 0.81
[Index for a pulmonary postoperative complication after upper abdominal surgery: a validation study]. Rev Assoc Med Bras (2002) 0.81
[Assessment of the quality of life of patients with lung cancer using the Medical Outcomes Study 36-item Short-Form Health Survey]. J Bras Pneumol (2008) 0.81
Survival rates and tolerability of platinum-based chemotherapy regimens for elderly patients with non-small-cell lung cancer (NSCLC). Lung Cancer (2006) 0.80
Discriminative aspects of SF-36 and QQL-EPM related to asthma control. J Asthma (2007) 0.79
Reliability of the Brazilian version of the Functional Assessment of Cancer Therapy-Lung (FACT-L) and the FACT-Lung Symptom Index (FLSI). Clinics (Sao Paulo) (2010) 0.78
Asthma, a chronic disease whose manifestations go beyond respiratory distress, physical limitation and impaired quality of life. J Bras Pneumol (2009) 0.77
Validation of a simplified quality-of-life questionnaire for socioeconomically deprived asthma patients. J Asthma (2005) 0.76
Performance of a word labeled visual analog scale in determining the degree of dyspnea during exercise-induced bronchoconstriction in children and adolescents with asthma. J Bras Pneumol (2010) 0.76
Relationship between the magnitude of symptoms and the quality of life: a cluster analysis of lung cancer patients in Brazil. J Bras Pneumol (2013) 0.76
Influence of oscillating positive expiratory pressure and the forced expiratory technique on sputum cell counts and quantity of induced sputum in patients with asthma or chronic obstructive pulmonary disease. J Bras Pneumol (2008) 0.75
[Evaluation of acute bacterial rhinosinusitis in asthma patients based on clinical parameters and imaging studies, together with ear, nose and throat examination]. J Bras Pneumol (2008) 0.75
Evaluation of diagnostic criteria for severe asthma described in a public health directive regulating the free distribution of medications for the maintenance treatment of asthma. J Bras Pneumol (2009) 0.75
Pharmaceutical equivalence of the combination formulation of budesonide and formoterol in a single capsule with a dry powder inhaler. J Bras Pneumol (2013) 0.75